The Hydration Pharmaceuticals Company Limited (ASX:HPC)

ASX:HPC Revenue

The Hydration Pharmaceuticals Company had revenue of $1.20M USD in the half year ending June 30, 2026, a decrease of -33.22%. This brings the company's revenue in the last twelve months to $2.15M, down -26.62% year-over-year. In the year 2025, The Hydration Pharmaceuticals Company had annual revenue of $2.47M, down -22.88%.

• Revenue (ttm): $2.15M
• Revenue Growth: -26.62%
• P/S Ratio: 0.52
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.61M AUD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.47M	-733.21K	-22.88%
Dec 31, 2024	3.20M	-1.10M	-25.48%
Dec 31, 2023	4.30M	-4.80M	-52.74%
Dec 31, 2022	9.10M	2.97M	48.52%
Dec 31, 2021	6.13M	2.37M	63.10%

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 24, 2026

Data Sources Report a data error